Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma.

November 9, 2011


American Cancer Society

Publication Date

November 9, 2011


Ryan C. Fields MD, Klaus J. Busam MD, Joanne F. Chou MPH, Katherine S. Panageas DrPH, Melissa P. Pulitzer MD, Peter J. Allen MD, Dennis H. Kraus MD, Mary S. Brady MD, Daniel G. Coit MD

Download PDF


Merkel cell carcinoma (MCC) is a rare cutaneous neuroendocrine neoplasm whose natural history is poorly understood. Here, the authors describe their experience with a large cohort of patients who were treated at a single institution to describe patterns of recurrence after curative therapy.

View the clinical publication